Apostolos Pharmaceuticals Pvt Ltd
About Apostolos Pharmaceuticals Pvt Ltd
Data last updated:
Apostolos Pharmaceuticals Pvt Ltd was a private limited company based in Thane, Maharashtra, India, operated as a subsidiary of The Reliance Investment Company Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 12 February 1992.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1992PTC065391.
The company had an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Geeta Ashok Bhave and Ravi Chettuvatty Menon.
Its last annual general meeting (AGM) was held on 26 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Plot No R – 239 T C Industrial Area M I D C Rabale Thane Belapur Road, Maharashtra, India – 400701.
Its group structure included 2 subsidiaries.
Company details
Contact details
Apostolos Pharmaceuticals Pvt Ltd's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No R – 239 T C Industrial Area M I D C Rabale Thane Belapur Road, Maharashtra, India – 400701
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Apostolos Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Apostolos Pharmaceuticals Pvt Ltd
FY 2017 filings availableApostolos Pharmaceuticals Pvt Ltd reported revenue of ₹8,789 (down 26% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue fell 26% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹8,789 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Apostolos Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Apostolos Pharmaceuticals Pvt Ltd
Apostolos Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Geeta Ashok Bhave | Director | 27 Jan 2004 | 22 Years 8 Months | As last reported |
| Ravi Chettuvatty Menon Also directs: S S Computer Services LLP, Lee Packaging Private Limited | Director | 09 Sep 2008 | 18 Years 1 Months | As last reported |
| Siddesh Niranjan Sigtia Also directs: Sigtia Trade & Logistics LLP, SNS Commodities & Trading LLP, The Equus Stud Pvt Ltd and 2 more | Additional Director | 04 Sep 2017 | 9 Years 1 Months | As last reported |
Peer comparison
Apostolos Pharmaceuticals Pvt Ltd is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VNW Pharmaceuticals Private Limited | ₹10,000 (FY 2024) | -78.0% | Thane, Maharashtra, India | |||
| Encyclia Pharmaceuticals Private Limited | ₹10,000 (FY 2024) | -100.0% | Delhi, India | |||
| Equidius Pharmaceuticals Private Limited | ₹9,599 (FY 2019) | Pune, Maharashtra, India | ||||
| Rememax Pharmaceuticals Private Limited | ₹9,407 (FY 2025) | -99.0% | Kolkata, West Bengal, India | |||
| Gunbrj Pharmaceuticals Private Limited | ₹9,000 (FY 2015) | Bangalore, Karnataka, India | ||||
| Apostolos Pharmaceuticals Pvt Ltdthis company | ₹8,789 (FY 2017) | -26.0% | Thane, Maharashtra, India | |||
| Medicode Pharmaceuticals Private Limited | ₹8,619 (FY 2021) | Hyderabad, Telangana, India | ||||
| Vitota Life Sciences & Pharmaceuticals Private Limited | ₹8,200 (FY 2024) | Bhopal, Madhya Pradesh, India | ||||
| Nivera Pharmaceuticals Private Limited | ₹8,031 (FY 2023) | -70.0% | Bangalore, Karnataka, India | |||
| Lysten Global Pharmaceuticals Private Limited | ₹8,000 (FY 2023) | -97.0% | Kolhapur, Maharashtra, India | |||
| E L C Pharmaceuticals Private Limited | ₹8,000 (FY 2025) | -100.0% | New Delhi, Delhi, India |
To see the full peer comparison of Apostolos Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Apostolos Pharmaceuticals Pvt Ltd is audited by P. L. BHATIA & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P. L. BHATIA & CO | FY 2017 | 113919W |
Shareholding
The shareholding of Apostolos Pharmaceuticals Pvt Ltd is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Apostolos Pharmaceuticals Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Apostolos Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apostolos Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Apostolos Pharmaceuticals has 2 subsidiary companies and 1 associated company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Sattva Pharmaceuticals Private Limited | U24230MH1984PTC031774 | |
| Raptakos Brett Marketing Private Limited | U51900MH1999PTC118138 |
To see the full group structure of Apostolos Pharmaceuticals Pvt Ltd, buy the company report.
GST
No GST registration is on our record for Apostolos Pharmaceuticals Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Apostolos Pharmaceuticals Pvt Ltd has 6 board changes on record since 2004: 3 appointments and 3 cessations. The latest: Siddesh Niranjan Sigtia was appointed as Additional Director on 04 Sep 2017.
Frequently asked questions
Apostolos Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Apostolos Pharmaceuticals was a private limited company based in Thane, Maharashtra, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 12 February 1992 and is registered under CIN U24239MH1992PTC065391. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Apostolos Pharmaceuticals was incorporated on 12 February 1992. It is registered with the Registrar of Companies, Mumbai.
Apostolos Pharmaceuticals had 3 directors:
- Geeta Ashok Bhave - Director
- Ravi Chettuvatty Menon - Director
- Siddesh Niranjan Sigtia - Additional Director
The CIN (Corporate Identification Number) of Apostolos Pharmaceuticals is U24239MH1992PTC065391. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Apostolos Pharmaceuticals is at Plot No R – 239 T C Industrial Area M I D C Rabale Thane Belapur Road, Maharashtra, India – 400701.
The latest financial statements of Apostolos Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 26 September 2017. Year-wise statements from 2015 are in the company report.
Apostolos Pharmaceuticals operated in the chemicals industry, in the other chemical product segment.
The peers of Apostolos Pharmaceuticals by revenue are VNW Pharmaceuticals Private Limited, Encyclia Pharmaceuticals Private Limited, Equidius Pharmaceuticals Private Limited, Rememax Pharmaceuticals Private Limited, Gunbrj Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Siddesh Niranjan Sigtia was appointed as Additional Director on 04 Sep 2017. Ravi Chettuvatty Menon ceased to be Additional Director on 29 Sep 2016. Loknath Nemu Anchan ceased to be Alternate Director on 01 Mar 2010. Apostolos Pharmaceuticals has 6 board changes on record in total.
Apostolos Pharmaceuticals has 2 subsidiary companies including Sattva Pharmaceuticals Private Limited, Raptakos Brett Marketing Private Limited.